CDMO News
PCI Pharma Services Secures New Investment to Accelerate Global CDMO Growth
PCI Pharma Services, a global contract development and manufacturing organisation (CDMO), has announced a new strategic investment to accelerate its growth and service expansion. The investment is co-led by Bain Capital and existing lead investor Kohlberg, with significant reinvestment from
15 July 2025